Pular para o conteúdo principal
Ranking Invest

SNN - Smith & Nephew plc

Segmento: HealthcareSmith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Análise Ranking Invest

Valor de Mercado
$ 12.60 Bi
IVR
0.68Índice proprietário de comparação relativa: 0,68.
IVR2
0.28Leitura proprietária complementar: 28%.
MLL
0.28Leitura proprietária complementar: 28%.
Último Balanço Atualizado: 4T2024

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 5.26 Bi

Dívida Líquida

$ 2.70 Bi

L4T

$ 675.00 Mi

MM4T

5.93%

Indicadores Básicos

ROE

12.82%

Índices de Previsibilidade

Receita Líquida

B0.03

Lucro

C0.30

Margem

B0.30

Índices de Tendência

Receita Líquida

B9.02

Lucro

G-8.02

Margem

G-8.96

Índices de Endividamento

DIV/PAT

0.51

DIV/L4T

4.00

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.